210 related articles for article (PubMed ID: 32206120)
1. CAMSAP2-mediated noncentrosomal microtubule acetylation drives hepatocellular carcinoma metastasis.
Li D; Ding X; Xie M; Huang Z; Han P; Tian D; Xia L
Theranostics; 2020; 10(8):3749-3766. PubMed ID: 32206120
[No Abstract] [Full Text] [Related]
2. Noncentrosomal microtubules regulate autophagosome transport through CAMSAP2-EB1 cross-talk.
Wei J; Xu H; Meng W
FEBS Lett; 2017 Aug; 591(16):2379-2393. PubMed ID: 28726242
[TBL] [Abstract][Full Text] [Related]
3. CAMSAP2 promotes colorectal cancer cell migration and invasion through activation of JNK/c-Jun/MMP-1 signaling pathway.
Wang X; Liu Y; Ding Y; Feng G
Sci Rep; 2022 Oct; 12(1):16899. PubMed ID: 36207462
[TBL] [Abstract][Full Text] [Related]
4. EB2 promotes hepatocellular carcinoma proliferation and metastasis via MAPK/ERK pathway by modulating microtubule dynamics.
Zhong FJ; Li YM; Xu C; Sun B; Wang JL; Yang LY
Clin Sci (Lond); 2021 Apr; 135(7):847-864. PubMed ID: 33755094
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP.
Dang Y; Chen J; Feng W; Qiao C; Han W; Nie Y; Wu K; Fan D; Xia L
Theranostics; 2020; 10(8):3833-3848. PubMed ID: 32206125
[No Abstract] [Full Text] [Related]
6. Nezha/CAMSAP3 and CAMSAP2 cooperate in epithelial-specific organization of noncentrosomal microtubules.
Tanaka N; Meng W; Nagae S; Takeichi M
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20029-34. PubMed ID: 23169647
[TBL] [Abstract][Full Text] [Related]
7. Microtubule minus-end stabilization by polymerization-driven CAMSAP deposition.
Jiang K; Hua S; Mohan R; Grigoriev I; Yau KW; Liu Q; Katrukha EA; Altelaar AF; Heck AJ; Hoogenraad CC; Akhmanova A
Dev Cell; 2014 Feb; 28(3):295-309. PubMed ID: 24486153
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathway of Microtubule Organization at the Golgi Apparatus.
Wu J; de Heus C; Liu Q; Bouchet BP; Noordstra I; Jiang K; Hua S; Martin M; Yang C; Grigoriev I; Katrukha EA; Altelaar AFM; Hoogenraad CC; Qi RZ; Klumperman J; Akhmanova A
Dev Cell; 2016 Oct; 39(1):44-60. PubMed ID: 27666745
[TBL] [Abstract][Full Text] [Related]
9. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
[TBL] [Abstract][Full Text] [Related]
10. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
11. EB1 and EB3 regulate microtubule minus end organization and Golgi morphology.
Yang C; Wu J; de Heus C; Grigoriev I; Liv N; Yao Y; Smal I; Meijering E; Klumperman J; Qi RZ; Akhmanova A
J Cell Biol; 2017 Oct; 216(10):3179-3198. PubMed ID: 28814570
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
13. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
[TBL] [Abstract][Full Text] [Related]
14. Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis.
Xiang X; Kuang W; Yu C; Li Y; Su Q; Tian Y; Li J
Mol Carcinog; 2023 Dec; 62(12):1974-1989. PubMed ID: 37792308
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
16. Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1.
Cao X; Zhang L; Shi Y; Sun Y; Dai S; Guo C; Zhu F; Wang Q; Wang J; Wang X; Chen YH; Zhang L
Mol Cancer; 2013 Nov; 12(1):149. PubMed ID: 24274578
[TBL] [Abstract][Full Text] [Related]
17. Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis.
Aiyama T; Orimo T; Yokoo H; Ohata T; Hatanaka KC; Hatanaka Y; Fukai M; Kamiyama T; Taketomi A
PLoS One; 2020; 15(9):e0239462. PubMed ID: 32956413
[TBL] [Abstract][Full Text] [Related]
18. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
19. Promoting colonization in metastatic HCC cells by modulation of autophagy.
Peng YF; Shi YH; Shen YH; Ding ZB; Ke AW; Zhou J; Qiu SJ; Fan J
PLoS One; 2013; 8(9):e74407. PubMed ID: 24058558
[TBL] [Abstract][Full Text] [Related]
20. PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway.
Yang QX; Zhong S; He L; Jia XJ; Tang H; Cheng ST; Ren JH; Yu HB; Zhou L; Zhou HZ; Ren F; Hu ZW; Gong R; Huang AL; Chen J
Cancer Lett; 2019 Jun; 452():90-102. PubMed ID: 30914208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
